Figure 6 | Scientific Reports

Figure 6

From: A novel immune-related gene signature for predicting immunotherapy outcomes and survival in clear cell renal cell carcinoma

Figure 6

(A) The expression level of several salient checkpoints (CTLA4, CD274, PDCD1LG2, SIGLEC15, TIGIT, HAVCR2, LAG3, and PDCD1) between low- and high- riskscore groups based on TCGA-KIRC. (B) The difference in IPS between low- and high- riskscore groups. IPS: Immunophenoscore. IPS-A: CTLA4 blocker, IPS-B: PD1/PDL1/PDL2 blocker and IPS-C: CTLA4 and PD1/PDL1/PDL2 blocker.

Back to article page